Shionogi

4507.TSE

17.29 USD

0.28

+1.65%

Overview

Last close

17.29 usd

Market cap

14.71B usd

52 week high

18.38 usd

52 week low

12.04 usd

Target price

17.15 usd

Valuation

P/E

12.5156

Forward P/E

15.4083

Price/Sales

4.8436

Price/Book Value

1.548

Enterprise Value

10.59B usd

EV/Revenue

3.6312

EV/EBITDA

6.8981

Key financials

Revenue TTM

2.93B usd

Gross Profit TTM

2.52B usd

EBITDA TTM

1.23B usd

Earnings per Share

1.33 usd

Dividend

0.41 usd

Total assets

10.68B usd

Net debt

-1.62B usd

About

Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.